Catalyst Pharmaceuticals Statistics
Total Valuation
CPRX has a market cap or net worth of $2.91 billion. The enterprise value is $2.33 billion.
| Market Cap | 2.91B |
| Enterprise Value | 2.33B |
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CPRX has 121.98 million shares outstanding. The number of shares has increased by 8.38% in one year.
| Current Share Class | 121.98M |
| Shares Outstanding | 121.98M |
| Shares Change (YoY) | +8.38% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 7.47% |
| Owned by Institutions (%) | 79.85% |
| Float | 112.81M |
Valuation Ratios
The trailing PE ratio is 15.19 and the forward PE ratio is 17.87. CPRX's PEG ratio is 1.58.
| PE Ratio | 15.19 |
| Forward PE | 17.87 |
| PS Ratio | 5.33 |
| Forward PS | 5.14 |
| PB Ratio | 3.66 |
| P/TBV Ratio | 4.49 |
| P/FCF Ratio | 10.86 |
| P/OCF Ratio | 10.85 |
| PEG Ratio | 1.58 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.65, with an EV/FCF ratio of 8.70.
| EV / Earnings | 11.80 |
| EV / Sales | 4.36 |
| EV / EBITDA | 8.65 |
| EV / EBIT | 10.07 |
| EV / FCF | 8.70 |
Financial Position
The company has a current ratio of 6.14, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.14 |
| Quick Ratio | 5.85 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 29.11% and return on invested capital (ROIC) is 21.23%.
| Return on Equity (ROE) | 29.11% |
| Return on Assets (ROA) | 18.59% |
| Return on Invested Capital (ROIC) | 21.23% |
| Return on Capital Employed (ROCE) | 29.02% |
| Revenue Per Employee | $2.95M |
| Profits Per Employee | $1.09M |
| Employee Count | 181 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 4.44 |
Taxes
In the past 12 months, CPRX has paid $61.11 million in taxes.
| Income Tax | 61.11M |
| Effective Tax Rate | 23.64% |
Stock Price Statistics
The stock price has increased by +49.50% in the last 52 weeks. The beta is 0.70, so CPRX's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +49.50% |
| 50-Day Moving Average | 23.02 |
| 200-Day Moving Average | 21.53 |
| Relative Strength Index (RSI) | 53.37 |
| Average Volume (20 Days) | 1,016,053 |
Short Selling Information
The latest short interest is 8.01 million, so 6.57% of the outstanding shares have been sold short.
| Short Interest | 8.01M |
| Short Previous Month | 7.79M |
| Short % of Shares Out | 6.57% |
| Short % of Float | 7.10% |
| Short Ratio (days to cover) | 6.71 |
Income Statement
In the last 12 months, CPRX had revenue of $534.65 million and earned $197.35 million in profits. Earnings per share was $1.57.
| Revenue | 534.65M |
| Gross Profit | 446.46M |
| Operating Income | 231.37M |
| Pretax Income | n/a |
| Net Income | 197.35M |
| EBITDA | 269.17M |
| EBIT | 231.37M |
| Earnings Per Share (EPS) | $1.57 |
Balance Sheet
The company has $580.66 million in cash and $3.09 million in debt, giving a net cash position of $577.57 million or $4.74 per share.
| Cash & Cash Equivalents | 580.66M |
| Total Debt | 3.09M |
| Net Cash | 577.57M |
| Net Cash Per Share | $4.74 |
| Equity (Book Value) | 794.28M |
| Book Value Per Share | 6.51 |
| Working Capital | 574.07M |
Cash Flow
In the last 12 months, operating cash flow was $267.93 million and capital expenditures -$357,000, giving a free cash flow of $267.57 million.
| Operating Cash Flow | 267.93M |
| Capital Expenditures | -357,000 |
| Free Cash Flow | 267.57M |
| FCF Per Share | $2.19 |
Margins
Gross margin is 83.50%, with operating and profit margins of 43.27% and 36.91%.
| Gross Margin | 83.50% |
| Operating Margin | 43.27% |
| Pretax Margin | 48.34% |
| Profit Margin | 36.91% |
| EBITDA Margin | 50.35% |
| EBIT Margin | 43.27% |
| FCF Margin | 50.05% |
Dividends & Yields
CPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.38% |
| Shareholder Yield | -8.38% |
| Earnings Yield | 6.79% |
| FCF Yield | 9.21% |
Analyst Forecast
The average price target for CPRX is $32.29, which is 35.50% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.29 |
| Price Target Difference | 35.50% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 12.03% |
| EPS Growth Forecast (5Y) | 29.57% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPRX has an Altman Z-Score of 14.86 and a Piotroski F-Score of 6.
| Altman Z-Score | 14.86 |
| Piotroski F-Score | 6 |